Skip to main content
AVTR logo

AVTR · Avantor, Inc.

Track AVTR — free
$15.32 -0.22 (-1.42%)
Market Cap
$10.38B
Shares
677.62M
Volume · Nov 16 6.15M Avg daily vol (3M) 8.63M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$15.32 Open$15.46 Day$15.27–15.62 52W close$7.41–17.29 Avg vol 30d9.5M Short int26.9M · 4.0% of shares · 2.0d Short vol56% Last earningsOct 28, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 28

Up next

Feb 10, 2027 Est · unconfirmed · in 12 wks

Latest documents

2026
Nov 3
Current report 8-K Events of Oct 30
Claudius Sokenu Receives 62,305 Special RSUs

Avantor granted Executive Vice President, Chief Legal and Compliance Officer and Secretary Claudius Sokenu 62,305 restricted stock units on October 31, 2026, vesting in equal installments over the first three anniversaries.

Director or officer change, or executive pay
Source passage
On October 30, 2026, the Compensation and Human Resources Committee (the “Committee”) of the Board of Directors of Avantor, Inc. (the “Company”) approved a special long-term incentive award for the Company’s Executive Vice President, Chief Legal and Compliance Officer and Secretary, Claudius Sokenu, to recognize his overall performance and contributions to the Company, including his leadership in litigation and regulatory management, dispute resolution and corporate governance. The award was granted on October 31, 2026, and is a grant of 62,305 restricted stock units (“RSUs”) under the Company’s 2019 Equity Incentive Plan (the “Plan”). The RSUs will vest in equal installments on the first three anniversaries of the grant date, subject to Mr. Sokenu’s continued employment with the Company through each applicable vesting date. Open the document at this passage
Oct 28
Earnings call
Q3 2026 earnings call

Avantor returned to organic growth in Q3, posting 5.2% revenue growth and $0.22 adjusted EPS. It raised 2026 organic revenue growth guidance to 0.75 to 1.25%, adjusted EPS to $0.81 to $0.83, and free cash flow to $525 to $550 million.

Oct 28
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Avantor reported third-quarter net sales of $1,698.3 million, up 4.6%, and net income of $203.4 million, while Adjusted EBITDA declined $11.0 million. The VWR Distribution reporting unit faced potential goodwill impairment.

Revenue $1.7B ▲ 4.6% Net income $203.4M Diluted EPS $0.30
Read from the MD&A section
Oct 28
Current report 8-K
Financial results

Avantor's third-quarter net sales were $1,698.3 million, up 4.6% and 5.2% organically. It raised fiscal 2026 organic revenue growth guidance to +0.75% to +1.25% and free cash flow guidance to $525M to $550M.

Sep 21
Current report 8-K Events of Sep 17
Director or officer change, or executive pay, Regulation FD disclosure

Avantor, Inc. appointed Todd Garner Executive Vice President and Chief Financial Officer effective September 21, 2026, with $700,000 annual base salary, 80% target bonus, $150,000 signing bonus, and a targeted $1,500,000 initial equity grant.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$6.64B
Trailing 12 months
Net income (TTM)
$337.20M
Trailing 12 months
Revenue growth YoY
+4.6%
Year over year
Operating margin
7.3%
Trailing 12 months
P / E (TTM)
31.1
Trailing earnings · reciprocal yield 3.2%
FCF yield
4.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$3.22B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.1%
Year over year · fewer shares
Price change (1Y)
+34.6%
Trailing year
Short interest
4.0%
Latest settlement · 2.0 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Jul 29, 2026
Q2 FY26

TL;DR. Avantor raised its full-year 2026 organic revenue growth guidance to -0.5% to +0.5% and adjusted EPS guidance to $0.80–$0.83 after Q2 results beat expectations, with VWR returning to positive organic growth and the company repaying $112 million of debt while maintaining a 3.3x adjusted net leverage ratio. However, adjusted EBITDA and segment margins still declined year-over-year on mix and inflationary pressures, and FX is expected to be a headwind in the second half.

Bullish
  • + Raised full-year 2026 organic revenue growth guidance to -0.5% to +0.5% (from -2.5% to -0.5%)
  • + Raised full-year 2026 adjusted EPS guidance to $0.80–$0.83 (from $0.77–$0.83)
  • + VWR Distribution & Services returned to positive organic revenue growth of 1.7% in Q2
  • + Q2 free cash flow of $142.8 million (or $152 million excluding cash restructuring costs) ahead of expectations
Bearish
  • − Total adjusted EBITDA margin declined to 15.0% in Q2 from 16.6% year-over-year
  • − FX expected to be a headwind to reported revenue in the second half of 2026
  • − GAAP net income fell to $38.1 million in Q2 from $64.7 million in Q2 2025

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Fair Quant / Vol High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +34%
above
Price vs 50-day avg −2%
below
RSI (14) 42
neutral
MACD trend Negative
52-week position 80%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −6%
trailing
6-month return +82%
trailing
YTD return +34%
this year
Relative strength +84%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $16 › 200d $11 — 50d above 200d
Institutional flow Distributing
-10% holders QoQ · +75 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.97% of shares out · ▼ -22.3% MoM · 2.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
417 holders — near 3-yr low, contrarian setup
Squeeze score 41
elevated · 0–100
Fundamentals
Fair
Revenue growth −3%
Y/Y
Gross margin 33%
contracting
EPS growth −175%
Y/Y
Free cash flow $495.0M
Valuation P/E 30.6
below peers
Buyback $425.0M
remaining
Balance sheet $3.6B
net debt
Quant / Vol
risk profile
High
Volatility 43%
annualized · 1-yr
Max drawdown −41%
past year
ATR 3.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jul 29, 2026
2026
Adjusted EPS Non-GAAP $0.80 – $0.83
Free cash flow $500M – $550M
the full year
Adjusted EPS Non-GAAP $0.80 – $0.83
Previous outlook earlier release · from the Earnings Call filed Apr 29, 2026

Still-open targets the latest release did not restate under the same label.

Operating income headwind from inflationary pressures · 2026 $10M – $20M
Free cash flow · full year $500M – $550M
Prior guidance period ended · from the Earnings Call filed Jul 29, 2026
Adjusted EPS · Q3 2026 $0.20 – $0.21

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 5 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+34% Bullish
Price vs 50-day avg
−2% Neutral
RSI (14)
42 Neutral
MACD trend
Negative Bearish
52-week position
80% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $16 › 200d $11 — 50d above 200d
Institutional flow Distributing
-10% holders QoQ · +75 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.97% of shares out · ▼ -22.3% MoM · 2.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
417 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $7 Now $15 · 80% Range high $17
vs 200-day avg +34% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $254.3M the three months ended June 30, 2026 filing —
Adjusted EBITDA margin non-GAAP 15% three months ended June 30, 2026 filing —
Adjusted Operating Income non-GAAP 225.1M Three months ended June 30, 2026 filing —
Adjusted Operating Income - Bioscience & Medtech Products non-GAAP $117.6M three months ended June 30, 2026 filing —
Adjusted Operating Income - Corporate non-GAAP -$18.9M three months ended June 30, 2026 filing —
Adjusted Operating Income - VWR Distribution & Services non-GAAP $126.4M three months ended June 30, 2026 filing —
Adjusted Operating Income margin non-GAAP 13.3% three months ended June 30, 2026 filing —
Bioscience & Medtech Products depreciation and amortization $49.2M Three months ended June 30, 2026 filing —
Total depreciation and amortization $105.6M Three months ended June 30, 2026 filing —
VWR Distribution & Services depreciation and amortization $56.4M Three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AVTR
Avantor, Inc.
this stock
$10.38B +33.7% -3.4% 30.6 4.0%
ISRG
Intuitive Surgical Inc
$151.74B -22.7% +20.5% 53.1 2.0%
BDX
Becton Dickinson & Co
$58.96B — +8.2% 95.8 3.0%
MDLN
Medline Inc.
$51.52B -6.7% +11.5% — 2.9%
ALC
Alcon Inc
$35.38B -6.6% +10.5% — 3.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
417
% held
84.9%
Net QoQ
-123.8M sh
Top holder
Dodge & Cox
Held Float
View
Held by Funds
Fund positions
390
View
Short & Settlement
Short Interest Falling
Shares short
26.9M
Days to cover
2.0d
Change
-7.7M sh
View
Short Volume
Short vol %
56%
As of
Nov 16, 2026
Short Total
View
Fails to Deliver
FTD shares
175
Value
$3.0K
As of
Oct 22, 2026
View
Off-Exchange
Off-exchange %
42.2%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Gilbert Cisneros
Amount
$1.0K–$15.0K
Traded
Aug 13, 2025
View
Financials
Financials
Revenue (FY)
$6.6B
Net income (FY)
$-530.2M
EPS diluted
$-0.78
View
Buybacks
Authorized
$500.0M
Remaining
$425.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 3, 2026
This year
21

Avantor granted Executive Vice President, Chief Legal and Compliance Officer and Secretary Claudius Sokenu 62,305 restricted stock units on October 31, 2026, vesting in equal installments over the first three anniversaries.

View
Proposed Sales
Value
$732.9K
Shares
29.1K
Filed
Nov 6, 2025
View
Earnings & Events
Webcasts Upcoming
Next webcast
Dec 8, 2026
Last webcast
Oct 28, 2026
View
Investor Relations
Latest news
Avantor® Reports Third Quarter 20…
Published
Oct 28, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
AVTR -3.7% -6.0% +82.4% -4.6% +33.7%
SPY -1.7% -3.5% -1.4% -2.1% +8.5%
vs SPY -2.0% -2.5% +83.8% -2.5% +25.2%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
$500.00M
Spent (derived)
$75.00M
Remaining
$425.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1722482 CUSIP 05352A100 13F (30d) 414 filings 386 filers Visit website Investor relations